| lisdexamfetamine / Generic mfg. |
NCT00746733: Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC |
|
|
| Completed | 1 | 24 | US | Lisdexamfetamine Dimesylate, Adderall XR (mixed salts amphetamine) | Shire | Healthy Volunteers | 10/08 | 10/08 | | |
NCT00776555: Compare Subjective Drug Liking & Pharmacokinetics of Vyvanse™ and ADDERALL XR® When Administered as an Oral Solution |
|
|
| Terminated | 1 | 3 | US | Lisdexamfetamine Dimesylate, Racemic mixture of dextroamphetamine and lisdexamfetamine | Shire | Healthy | 03/09 | 03/09 | | |
NCT00919867: A Drug Interaction Study of SPD503 and Vyvanse Administered Alone and In Combination in Normal Healthy Volunteers |
|
|
| Completed | 1 | 42 | US | SPD503, guanfacine hydrochloride, VYVANSE, lisdexamfatamine dimesylate (LDX), SPD503 and VYVANSE | Shire | Healthy | 07/09 | 07/09 | | |
NCT01010750: Lisdexamfetamine Dimesylate (LDX) Pilot Cognition Study to Evaluate the Utility of a Standardized Battery of Tests in Adults With Attention-Deficit Hyperactivity Disorder (ADHD) |
|
|
| Completed | 1 | 18 | US | Lisdexamfetamine Dimesylate (LDX), Immediate Release Mixed Amphetamine Salts (MAS-IR), LDX Placebo + MAS-IR Placebo | Shire | Attention-Deficit Hyperactivity Disorder | 03/10 | 03/10 | | |
NCT01235338: Co-Administration of LDX (SPD489) and Venlafaxine XR (EFFEXOR XR) in Healthy Volunteers |
|
|
| Completed | 1 | 80 | US | LDX + Venlafaxine XR, Lisdexamfetamine dimesylate, LDX, Vyvanse, SPD489; Venlafaxine hydrochloride extended-release, Effexor XR,, Venlafaxine XR + LDX, Venlafaxine hydrochloride extended-release, Effexor XR; Lisdexamfetamine dimesylate, LDX, Vyvanse, SPD489 | Shire | Healthy | 12/10 | 01/11 | | |
NCT01457339: Assess the Safety and Pharmacokinetics of Ascending, Multiple Oral Doses of SPD489 in Adults With Schizophrenia |
|
|
| Completed | 1 | 31 | US | SPD489 (Lisdexamfetamine dimesylate), Vyvanse, LDX, Placebo | Shire | Schizophrenia | 01/12 | 01/12 | | |
NCT01490216: Pilot Study of Lisdexamfetamine for Treatment of Cocaine Dependence |
|
|
| Terminated | 1 | 43 | US | lisdexamfetamine, vyvanse | University of Minnesota | Cocaine Dependence | 01/13 | 01/13 | | |
NCT01890785: Bioavailability Study of SPD489 Administered With Two Different Means of Administration in Healthy Adult Volunteers |
|
|
| Completed | 1 | 30 | US | Lisdexamfetamine Dimesylate, SPD489 | Shire | Healthy Volunteers | 08/13 | 08/13 | | |
NCT02144415: A Study to Evaluate the Abuse Potential of EB-1020 Immediate-Release in Healthy Recreational Stimulant Users |
|
|
| Completed | 1 | 80 | US | EB-1020 400 mg, EB-1020 800 mg, lisdexamfetamine 150 mg, d-amphetamine 40 mg, Placebo | Neurovance, Inc. | Healthy Volunteers, Drug Users | 07/14 | 07/14 | | |
NCT02034201: Clinical Efficacy of Lisdexamfetamine for Methamphetamine Dependence |
|
|
| Completed | 1 | 19 | US | Lisdexamfetamine, Placebo | University of Arkansas, National Institute on Drug Abuse (NIDA) | Methamphetamine Dependence | 05/16 | 05/16 | | |
| Completed | 1 | 24 | Europe | Lisdexamfetamine, d-amphetamine, Placebo, Lisdexamfetamine=Elvanse, d-amphetamine=d-amphetamine sulfate, d-amphetamine, Placebo, Lisdexamfetamine, Placebo, Lisdexamfetamine, d-amphetamine | University Hospital, Basel, Switzerland | Healthy | 06/16 | 12/16 | | |
| Recruiting | 1 | 40 | US | Lisdexamfetamine Dimesylate, Lifestyle therapy | University of Minnesota | Obesity, Childhood | 11/28 | 11/29 | | |
